drugset / Trial / NCT00003748
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have esophageal or stomach cancer.
Timeline
- Start
- 1998-08
- Primary completion
- 2000-06
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 125 mg/m2 | Intravenous |